Literature DB >> 30066173

Alterations in the Gut Microbiota of Rats Chronically Exposed to Volatilized Cocaine and Its Active Adulterants Caffeine and Phenacetin.

Cecilia Scorza1, Claudia Piccini2, Marcela Martínez Busi3, Juan Andrés Abin Carriquiry3, Pablo Zunino4.   

Abstract

A role of the gut microbiota in influencing brain function and emotional disorders has been suggested. However, only a few studies have investigated the gut microbiota in the context of drug addiction.Cocaine can be smoked (i.e., crack or coca paste) and its consumption is associated with a very high abuse liability and toxicity. We have recently reported that cocaine base seized samples contained caffeine and phenacetin as main active adulterants, which may potentiate its motivational, reinforcing, and toxic effects. However, the effect of volatilized cocaine and adulterants on the gut microbiota remained unknown. In the present study, we evaluated the effect of volatilized cocaine and two adulterants on the structure, diversity, and functionality of the gut microbiota in rats. Animals were chronically exposed to the fume of cocaine, caffeine, and phenacetin during 14 days. At the end of the treatment, feces were collected and the structure, composition, and functional predictions of the gut microbiota were analyzed. Cocaine significantly decreased the community richness and diversity of the gut microbiota while both cocaine and phenacetin drastically changed its composition. Phenacetin significantly increased the Firmicutes-Bacteroidetes ratio compared to the control group. When the predicted metagenome functional content of the bacterial communities was analyzed, all the treatments induced a dramatic decrease of the aromatic amino acid decarboxylase gene. Our findings suggest that repeated exposure to volatilized cocaine, as well as to the adulterants caffeine and phenacetin, leads to changes in the gut microbiota. Future studies are needed to understand the mechanisms underlying these changes and how this information may support the development of novel treatments in drug addiction.

Entities:  

Keywords:  Addiction; Adulterants; Cocaine; Gut-brain axis; Microbiota

Mesh:

Substances:

Year:  2018        PMID: 30066173     DOI: 10.1007/s12640-018-9936-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  13 in total

1.  Multimodal neurocognitive markers of interoceptive tuning in smoked cocaine.

Authors:  Alethia de la Fuente; Lucas Sedeño; Sofia Schurmann Vignaga; Camila Ellmann; Silvina Sonzogni; Laura Belluscio; Indira García-Cordero; Eugenia Castagnaro; Magdalena Boano; Marcelo Cetkovich; Teresa Torralva; Eduardo T Cánepa; Enzo Tagliazucchi; Adolfo M Garcia; Agustín Ibañez
Journal:  Neuropsychopharmacology       Date:  2019-03-13       Impact factor: 7.853

Review 2.  A potential role for the gut microbiome in substance use disorders.

Authors:  Katherine R Meckel; Drew D Kiraly
Journal:  Psychopharmacology (Berl)       Date:  2019-04-14       Impact factor: 4.530

3.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

4.  Oral Enrichment of Streptococcus and its Role in Systemic Inflammation Related to Monocyte Activation in Humans with Cocaine Use Disorder.

Authors:  Xiaoyu Fu; Da Cheng; Zhenwu Luo; Amanda Wagner; Sylvia Fitting; Xiaomei Cong; Wanli Xu; Kendra Maas; Zhuang Wan; Jian Zhu; Zejun Zhou; William W Stoops; Aimee McRae-Clark; Wei Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-26       Impact factor: 7.285

5.  Early-Life Exposure to Non-Absorbable Broad-Spectrum Antibiotics Affects the Dopamine Mesocorticolimbic Pathway of Adult Rats in a Sex-Dependent Manner.

Authors:  Camila González-Arancibia; Victoria Collio; Francisco Silva-Olivares; Paula Montaña-Collao; Jonathan Martínez-Pinto; Marcela Julio-Pieper; Ramón Sotomayor-Zárate; Javier A Bravo
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 6.  Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders.

Authors:  Kelsey E Lucerne; Aya Osman; Katherine R Meckel; Drew D Kiraly
Journal:  Neuropharmacology       Date:  2021-05-06       Impact factor: 5.273

7.  The role of gut-immune-brain signaling in substance use disorders.

Authors:  Kelsey E Lucerne; Drew D Kiraly
Journal:  Int Rev Neurobiol       Date:  2020-10-24       Impact factor: 4.280

Review 8.  Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders.

Authors:  Sierra Simpson; Rio Mclellan; Emma Wellmeyer; Frederic Matalon; Olivier George
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-25       Impact factor: 7.285

9.  Differences in Gut Microbial Diversity are Driven by Drug Use and Drug Cessation by Either Compulsory Detention or Methadone Maintenance Treatment.

Authors:  Qiaoyan Li; Siqi Chen; Ke Liu; Danfeng Long; Diru Liu; Zhengchao Jing; Xiaodan Huang
Journal:  Microorganisms       Date:  2020-03-13

10.  Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice.

Authors:  Mariana Angoa-Pérez; Branislava Zagorac; Andrew D Winters; Jonathan M Greenberg; Madison Ahmad; Kevin R Theis; Donald M Kuhn
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.